PT - JOURNAL ARTICLE AU - Michaela Gregorova AU - Daniel Morse AU - Tarcisio Brignoli AU - Joseph Steventon AU - Fergus Hamilton AU - Mahableshwar Albur AU - David Arnold AU - Matthew Thomas AU - Alice Halliday AU - Holly Baum AU - Christopher Rice AU - Matthew B. Avison AU - Andrew D. Davidson AU - Marianna Santopaolo AU - Elizabeth Oliver AU - Anu Goenka AU - Adam Finn AU - Linda Wooldridge AU - Borko Amulic AU - Rosemary J. Boyton AU - Daniel M. Altmann AU - David K. Butler AU - Claire McMurray AU - Joanne Stockton AU - Sam Nicholls AU - Charles Cooper AU - Nicholas Loman AU - Michael J. Cox AU - Laura Rivino AU - Ruth C. Massey TI - Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia AID - 10.1101/2020.09.17.20190033 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.17.20190033 4099 - http://medrxiv.org/content/early/2020/09/22/2020.09.17.20190033.short 4100 - http://medrxiv.org/content/early/2020/09/22/2020.09.17.20190033.full AB - Here we describe the case of a COVID-19 patient who developed recurring ventilator-associated pneumonia caused by Pseudomonas aeruginosa that acquired increasing levels of antimicrobial resistance (AMR) in response to treatment. Metagenomic analysis revealed the AMR genotype, while immunological analysis revealed massive and escalating levels of T-cell activation. These were both SARS-CoV-2 and P. aeruginosa specific, and bystander activated, which may have contributed to this patient’s persistent symptoms and radiological changes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSouthmead Hospital Charity (Registered Charity Number: 1055900) Wellcome Trust (reference number: 212258/Z/18/Z) Elizabeth Blackwell Institute, University of Bristol Cystic Fibrosis Trust PhD studentship (CF Trust SRC 015). UKRI (MR/S019553/1 & MR/R02622X/1) Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval via South Yorkshire REC: 20/YH/0121, CRN approval no: 45469 NHS Research Ethics Committee approval ref 14/WA/1253All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is freely available